The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease

Int J Geriatr Psychiatry. 1999 Jan;14(1):3-47. doi: 10.1002/(sici)1099-1166(199901)14:1<3::aid-gps897>3.0.co;2-7.

Authors

R Cacabelos¹, M Takeda, B Winblad

Affiliation

¹ Institute for CNS Disorders, EuroEspes Biomedical Research Center, La Coruña, Spain. euroespes@lcg.servicom.es

PMID: 10029935
DOI: 10.1002/(sici)1099-1166(199901)14:1<3::aid-gps897>3.0.co;2-7

No abstract available

Publication types

Review

MeSH terms

Aged
Alzheimer Disease / physiopathology
Alzheimer Disease / prevention & control*
Apolipoproteins E / genetics
Brain / pathology
Humans
Receptors, Glutamate / physiology*
Risk Assessment

Substances

Apolipoproteins E
Receptors, Glutamate